Publications by authors named "Kelli Walters"

Claim this Profile
U
Using Drosophila melanogaster to identify chemotherapy toxicity genes.
Elizabeth G King, Galina Kislukhin, Kelli N Walters, Anthony D Long

Genetics· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The genetic architecture of methotrexate toxicity is similar in Drosophila melanogaster and humans.
Galina Kislukhin, Elizabeth G King, Kelli N Walters, Stuart J Macdonald, Anthony D Long

G3 (Bethesda)· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction: characterizing the clinical relevance of an embryonic stem cell phenotype in lung adenocarcinoma.
Marvaretta Stevenson, William Mostertz, Chaitanya R Acharya, William Kim, Kelli Walters

Clin Cancer Res· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction: Acharya CR, et al. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer. JAMA. 2008;299(13):1574-1587.
Chaitanya R Acharya, David S Hsu, Carey K Anders, Ariel Anguiano, Kelly H Salter, Kelli S Walters

JAMA· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction: An integrated approach to the prediction of chemotherapeutic response in patients with breast cancer.
Kelly H. Salter, Chaitanya R. Acharya, Kelli S. Walters, Richard Redman, Ariel Anguiano

PLoS One· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age- and sex-specific genomic profiles in non-small cell lung cancer.
William Mostertz, Marvaretta Stevenson, Chaitanya Acharya, Isaac Chan, Kelli Walters

JAMA· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing the clinical relevance of an embryonic stem cell phenotype in lung adenocarcinoma.
Marvaretta Stevenson, William Mostertz, Chaitanya Acharya, William Kim, Kelli Walters

Clin Cancer Res· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An integrated approach to the prediction of chemotherapeutic response in patients with breast cancer.
Kelly H Salter, Chaitanya R Acharya, Kelli S Walters, Richard Redman, Ariel Anguiano

PLoS One· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer.
Chaitanya R Acharya, David S Hsu, Carey K Anders, Ariel Anguiano, Kelly H Salter, Kelli S Walters

JAMA· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer.
David S Hsu, Bala S Balakumaran, Chaitanya R Acharya, Vanja Vlahovic, Kelli S Walters

J Clin Oncol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis